三个皮匠报告
最新
报告分类 研搜
BETA
政策库
自研报告
new
入驻
搜索
您的当前位置：首页 > 行业数据 > IBI363vs竞品：治疗末线CRC的疗效与安全性
图片属性
图片格式：PNG 图片大小：151KB 图片尺寸：1819*858
同报告图片
 / 4
IBI363vs竞品：治疗末线CRC的疗效与安全性_第1页
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
IBI363vs竞品：治疗末线CRC的疗效与安全性_第2页
IBI363vs竞品：治疗末线CRC的疗效与安全性_第3页
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
IBI363vs竞品：治疗末线CRC的疗效与安全性_第4页
IBI363vs竞品：治疗末线CRC的疗效与安全性_第5页
所属报告： 医药健康行业专题研究：2025 ASCO （一）国产双抗ADC剑指FICBIC有望成难治肿瘤新解-250602（14页）.pdf
打包全文图表

相关数据

最新数据
全行业研究报告分享下载平台
  • 0731-84720580
  • 商务合作：really158d
关于我们
更多
关于我们
三个皮匠报告微信公众号
三个皮匠报告微信小程序
扫码咨询网站充值下载问题
copyright@2008-2013 长沙景略智创信息技术有限公司版权所有        网站备案/许可证号：湘B2-20190120 | 工信部备案号：湘ICP备17000430号-2 | 公安备案号：湘公网安备43010402001071号
客服
商务合作
小程序
服务号
折叠